Schizophrenia Clinical Trial
Official title:
Incidence of Psychological Comorbidities in Paediatric and Young Adults With Inflammatory Bowel Disease, and the Impacts on Quality-of-life, Disease Severity and Resource Utilisation: A Population-based Cohort Study in the United Kingdom
NCT number | NCT05206734 |
Other study ID # | P043 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 5, 2022 |
Est. completion date | August 15, 2023 |
Verified date | August 2023 |
Source | Momentum Data |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the risk of mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease, compared to those without Inflammatory Bowel Disease. The study will also compare the impacts on quality-of-life outcomes and use of healthcare services between people with Inflammatory Bowel Disease with and without mental health conditions.
Status | Completed |
Enrollment | 19469 |
Est. completion date | August 15, 2023 |
Est. primary completion date | March 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 5 Years to 25 Years |
Eligibility | Inclusion Criteria: - Aged between 5 years and 25 years - Registration with a general practices (GP) contributing routinely collected electronic healthcare data to the Optimum Patient Care Research Database (OPCRD) for more than 6 months during the follow up period - A recorded diagnosis of IBD in the clinical record (cases) Exclusion Criteria: • None |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Momentum Data Ltd | London |
Lead Sponsor | Collaborator |
---|---|
Momentum Data | Optimum Patient Care |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Stream 1 - Primary Outcome: Prevalence and cumulative incidence of mental health conditions in children, adolescents and young adults with IBD | Using routinely collected information from patient electronic medical record (EMR) data, we will investigate the prevalence and cumulative incidence of each mental health condition in cases with a diagnosis of IBD and controls without a diagnosis of IBD. Prevalence and cumulative incidence will be stratified by IBD type (Ulcerative Colitis, Crohn's Disease or IBD Unclassified). IBD classification status and mental health conditions will be identified on the basis diagnosis codes within their EMR. | Date of Inflammatory Bowel Disease diagnosis for cases or for controls date of diagnosis for their matched counterpart. End of follow-up will be the first of; point of data extraction, patients 25th birthday or loss to follow-up. | |
Primary | Stream 2 - Primary Outcome: Impact of mental health conditions in children, adolescents and young adults with IBD | Determine the association between mental health conditions in children, adolescents and young adults with Inflammatory Bowel Disease on quality-of-life indicators. These indicators will be gathered from the routinely collected EMR data, such as records for absence from work or school, unemployment, sleep disturbance and substance abuse. | Index date of 01/01/2015 with 5 years of follow-up. | |
Secondary | Stream 1 - Secondary outcome: Sequelae of mental health conditions in children, adolescents and young adults with IBD | Determine the sequelae of mental health conditions in people with and without Inflammatory Bowel Disease. Mental health disease information will be gathered from routinely collected EMR data using diagnosis codes for a range of mental health conditions, comprising of three core phenotypes: anxiety/panic disorders, major depressive disorders or depressive episodes, and other psychological conditions. Mental health condition sequelae will include any coded episode of self-harm or suicide, the development of additional chronic mental health conditions, and recorded sleep disturbance. | Date of Inflammatory Bowel Disease diagnosis for cases or for controls date of diagnosis for their matched counterpart. End of follow-up will be the first of; point of data extraction, patients 25th birthday or loss to follow-up. | |
Secondary | Stream 2 - Secondary outcome - IBD severity markers | Compare indicators of IBD severity in children, adolescents and young adults with and without mental health conditions. Indicators for disease severity will be gathered from the routinely collected EMR data, including records for medication use, surgical intervention, nutritional supplement prescriptions and markers of nutritional status including records of underweight or codes for growth retardation in children and adolescents, between those with and without mental health conditions. | Index date of 01/01/2015 with up to 5 years of follow-up. | |
Secondary | Stream 2 - Secondary outcome - Healthcare utilisation | Compare healthcare resource utilisation in children, adolescents and young adults with Inflammatory Bowel Disease with and without mental health conditions. Healthcare resource utilisation will comprise of records of number of primary care contacts and primary care records reporting hospital admission. Hospital admission will be separated into general admission (including for IBD) and psychiatric admission. | Index date of 01/01/2015 with up to 5 years of follow-up. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |